The use of unit dose packaging has taken on increased significance during the Covid-19 pandemic. In the midst of the crisis, much attention has been paid to drug administration in hospitals and other care facilities—and one risk factor, perhaps not […]
Read MoreThermo Fisher Scientific announced the construction of a new current good manufacturing practice (cGMP) plasmid DNA manufacturing facility in Carlsbad, CA. The 67,000-sq.-ft. site—which is expected to be completed in the first half of 2021—will expand the company’s clinical and […]
Read More
With a passion for furthering the advancement of cell therapy manufacturing, Fabian Gerlinghaus co-founded and helped launch Cellares, a startup focused on ways to make cell therapy more widely available and affordable. Pointing to the field’s still-new presence on the […]
Read MoreGermany-based Bayer AG recently launched a cell and gene therapy (C>) platform within its pharmaceuticals division. Stefan Oelrich, a member of the company’s Board of Management and president of the pharma division, says that with the rapid growth of C>, […]
Read MoreBuilding on a business relationship that was established in 2019, BioNTech SE and InstaDeep Ltd have struck a multi-year partnership that, companies say, will employ the most up-to-date developments in artificial intelligence (AI) and machine learning (ML) technology to develop […]
Read MoreEli Lilly’s investigational monoclonal antibody (mAb) bamlanivimab, which recently was issued emergency use authorization (EUA) by the FDA for Covid-19, is unlikely to face payer pushback, despite its broad label, GlobalData reports. The data and analytics company notes that drug prices have […]
Read More
While still a “card-carrying pharmacologist” today, Dr. Nicolette Louissaint points out proudly, the trained chemical engineer, with an accomplished academic background in biological and molecular sciences, has always had a superseding draw to biomedical research in the context of finding […]
Read MoreDirectors of the top sickle cell disease (SCD) programs in the US recently published the first set of recommendations for establishing SCD centers aimed at improving access to care for adults living with the debilitating, lifelong blood disease. The recommendations, which resulted from a […]
Read MoreSince its reign of terror began in the early 1980s, human immunodeficiency virus (HIV) has infected at least 76 million people worldwide. According to the World Health Organization (WHO), by the end of 2017, HIV-related disease had claimed 35 million […]
Read More
On the eve of the Am. Soc. of Clinical Oncologists meeting (June 1-5, Chicago), IQVIA has released its annual review of drug development and spending in oncology, Global Oncology Trends 2018. The topline finding is that global spending (therapeutic and […]
Read More
